JAK INHIBITOR FOR REVERSAL OF IMMUNE CHECKPOINT INHIBITOR DIABETES
About
Brief Summary
This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.
- If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
- If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.
Phase
Eligibility
Minimum Age
Maximum Age
Join this Trial
Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
25-0569
Category
Breast Cancer
Colorectal Cancer
Liver Cancer
Lung Cancer
Pancreatic Cancer
Prostate Cancer
Stomach Cancer
Principal Investigator
Contact
- Christy Sidhu